Zoetis Inc. (ZTS) Shares Outstanding: 0.44
Is Zoetis Inc.’s shares outstanding high or low?
Zoetis Inc.'s shares outstanding of 0.44 is in line with its 5-year average of 0.46, near the low end of its 5-year range (0.44–0.48).
The shares outstanding for Zoetis Inc. (ZTS) is 0.44. It is below its 12-month average by 1.20% (0.45).
ZTS Shares Outstanding Chart
ZTS Average Shares Outstanding Chart
ZTS Current vs Average Shares Outstanding Chart
ZTS Shares Outstanding Metrics
SHARES OUTSTANDING
0.44
SHARES OUTSTANDING AVG TTM
0.45
SHARES OUTSTANDING AVG 3Y
0.46
SHARES OUTSTANDING AVG 5Y
0.46
SHARES OUTSTANDING AVG 10Y
0.47
SHARES OUTSTANDING AVG 15Y
0.48
SHARES OUTSTANDING AVG 20Y
0.48
CURRENT VS TTM AVG
-1.20%
CURRENT VS 3Y AVG
-2.95%
CURRENT VS 5Y AVG
-4.21%
CURRENT VS 10Y AVG
-6.63%
CURRENT VS 15Y AVG
-7.63%
CURRENT VS 20Y AVG
-7.61%
Share Structure
Shares Outstanding
443.44M
Float Shares
N/A
Stock Price
$82.20
Market Cap
$34.5B
Annual Shares Outstanding History
| Year | Weighted Average Shares | YoY Change |
|---|---|---|
| 2025 | 443.44M | -2.37% |
| 2024 | 454.20M | -1.51% |
| 2023 | 461.17M | -1.65% |
| 2022 | 468.89M | -1.15% |
| 2021 | 474.35M | -0.24% |
| 2020 | 475.50M | -0.55% |
| 2019 | 478.13M | -1.02% |
| 2018 | 483.06M | -1.40% |
| 2017 | 489.92M | -1.17% |
| 2016 | 495.71M | -0.80% |
| 2015 | 499.71M | -0.27% |
| 2014 | 501.06M | +0.21% |
| 2013 | 500.00M | +0.00% |
| 2012 | 500.00M | +4.57% |
| 2011 | 478.13M | +0.00% |
| 2010 | 478.13M | +0.00% |
| 2009 | 478.13M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Zoetis Inc. Shares Outstanding Formula & Definition
Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Zoetis Inc. Shares Outstanding FAQ
- What is the shares outstanding for Zoetis Inc. (ZTS)?
- The shares outstanding for ZTS stock is 0.44.
- Is Zoetis Inc.'s shares outstanding high or low?
- Zoetis Inc.'s shares outstanding of 0.44 is in line with its 5-year average of 0.46, near the low end of its 5-year range (0.44–0.48).
- What is the TTM average shares outstanding for Zoetis Inc. (ZTS)?
- The TTM average shares outstanding for ZTS stock is 0.45.
- What is the 3Y average shares outstanding for Zoetis Inc. (ZTS)?
- The 3Y average shares outstanding for ZTS stock is 0.46.
- What is the 5Y average shares outstanding for Zoetis Inc. (ZTS)?
- The 5Y average shares outstanding for ZTS stock is 0.46.
- What is the 10Y average shares outstanding for Zoetis Inc. (ZTS)?
- The 10Y average shares outstanding for ZTS stock is 0.47.
- What is the 15Y average shares outstanding for Zoetis Inc. (ZTS)?
- The 15Y average shares outstanding for ZTS stock is 0.48.
- What is the 20Y average shares outstanding for Zoetis Inc. (ZTS)?
- The 20Y average shares outstanding for ZTS stock is 0.48.
Zoetis Inc. Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2025-12-31 | 0.44 |
| 2024-12-31 | 0.45 |
| 2023-12-31 | 0.46 |
| 2022-12-31 | 0.47 |
| 2021-12-31 | 0.47 |
| 2020-12-31 | 0.48 |
| 2019-12-31 | 0.48 |
| 2018-12-31 | 0.48 |
| 2017-12-31 | 0.49 |
| 2016-12-31 | 0.50 |
| 2015-12-31 | 0.50 |
| 2014-12-31 | 0.50 |
| 2013-12-31 | 0.50 |
| 2012-12-31 | 0.50 |
| 2011-12-31 | 0.48 |
| 2010-12-31 | 0.48 |
| 2009-12-31 | 0.48 |
Related Metrics
About Zoetis Inc.
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Kristin C. Peck